Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes. (Q51495176)
Jump to navigation
Jump to search
scientific article published in June 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes. |
scientific article published in June 2006 |
Statements
1 reference
Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes. (English)
1 reference
R E Pratley
1 reference
S Jauffret-Kamel
1 reference
E Galbreath
1 reference
D Holmes
1 reference
1 June 2006
1 reference
38
1 reference
423-428
1 reference
6
1 reference
Identifiers
1 reference